Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers

This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This prospective cohort study of HCW tested for anti-spike antibodies (LIAISON SARS-CoV-2 S1/S2 IgG assay) at 1, 3, 6, 9, and 12 months after receiving the second BNT162b2 vaccine dose (tests 1, 2, 3, 4,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Khetam, Dabaja-Younis, Halima, Szwarcwort-Cohen, Moran, Almog, Ronit, Leiba, Ronit, Weissman, Avi, Mekel, Michal, Hyams, Gila, Horowitz, Nethanel A., Gepstein, Vardit, Cohen Saban, Hagar, Tarabeia, Jalal, Halberthal, Michael, Shachor-Meyouhas, Yael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607254/
https://www.ncbi.nlm.nih.gov/pubmed/36298606
http://dx.doi.org/10.3390/vaccines10101741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607254/
https://www.ncbi.nlm.nih.gov/pubmed/36298606
http://dx.doi.org/10.3390/vaccines10101741

Ejemplares similares